Moreover, the miRNA-21 and miRNA-106b-25 cluster may trigger secondary events that eventually lead to full-blown disease, by targeting PTEN, BIM, and p21, which are tumour suppressants that inhibit survival and promote cell apoptosis in MM pathogenesis [16]. This evidence concerns the gene PTEN and Miyoshi myopathy.